SEC Form 4 · accession 0001140361-16-069721
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert B Catell
Director
Period of report
Jun 10, 2016
Accepted (ET)
Jun 14, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 50,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $3.73 | Jun 10, 2016 | A | 29,000 | A | — | Jun 10, 2026 | Common Stock | 29,000 | 29,000 | D |
| Stock OptionF1 | $3.70 | holding | — | — | — | — | Feb 19, 2026 | Common Stock | 15,000 | 15,000 | D |
| Warrant | $5.00 | holding | — | — | — | Mar 1, 2016 | Mar 1, 2021 | Common Stock | 37,500 | 37,500 | D |
| Warrant | $5.00 | holding | — | — | — | May 18, 2016 | May 18, 2021 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The option vests to the extent of 5,000 shares on each of February 19, 2017, 2018 and 2019.
- F2The option vests to the extent of 9,667 shares on each of June 10, 2016 and June 10, 2017, and 9,666 shares on June 10, 2018.